ABBOTT DIABETES CARE

Congress Materials

Advanced Technologies & Treatments for Diabetes

2026 Congress 

11 March – 14 March, 2026  |  Barcelona, Spain

Presentations and Materials

Poster

 

Profiling glutathione as a biomarker for erythrocyte cell age in individuals with and without diabetes.  

Joel D. Paprocki, Alan Cheng, Patrick J. Macdonald, Yongjin Xu, Qiaoqiao Ruan, and Timothy C. Dunn.

Poster

 

Data-driven identification of patients requiring insulin reduction using continuous glucose monitoring prior to GLP-1 RA initiation.  

Amruta Pai, Aparajita Bhattacharya, Anila Bindal, Byron Olson, Tim Dunn, Gary Hayter.

Poster

 

Experiences of Diabetes Management with FreeStyle Libre 2 among Adults with Type 2 Diabetes in Québec: A Focus Group Study  

Jean-François Yale, Sylvie Bouchard, Abraham Lee, Yeesha Poon.

Presentation

 

Uncovering Differences Between HbA1c and Mean CGM-Glucose During Pregnancy.  

Azin Mousavi, Eleanor Scott, Helen Murphy, Yongjin Xu, Tim Dunn, Tao Peng, Byron Olson, and Gary Hayter. 

Poster

 

Budget Impact Analysis Of Freestyle Libre Systems For People With Type 2 Diabetes On Basal Insulin – A European Perspective.

Johan Jendle, Jack Timmons, Donghyun D. Lee, Fleur Levrat-Guillen.

Presentation 

 

A qualitative study to understand providers' perspectives on hyperketonemia, diabetic ketoacidosis healthcare burden and ketone monitoring in type 1 and type 2 diabetes care.   

Jennifer Sherr, Abraham Lee, Yeesha Poon, Kathleen A. Willoughby, Anastasia Albanese-O’Neill, Jonathan Rosen, Melissa Culhane Maravic.

Presentation

 

The rising burden and risk factors for diabetic ketoacidosis in the United Kingdom: 20 years real world study in individuals with type 1 and type 2 diabetes  

Samuel Seidu, Clare Hambling, Ramzi Ajjan, Bethany Levick Shortall, Shea O’Connell, Chris Chesters, Fleur Levrat Guillen, Pratik Choudhary.

Presentation

 

Patients’ knowledge and barriers to ketone self-monitoring: results from a prospective survey of T1DM patients from the French SFDT1 Cohort.   

E. Cosson, B. Guerci, T. Ihaddadene-Salzgeber, C. Chesters, F. Levrat-Guillen, A. Bagel, S. Borot, J.-P. Riveline.

Presentation

 

Current GMI can over diagnose prediabetes with updated GMI and TITR mitigating this risk.  

Ramzi A. Ajjan, Timothy C. Dunn, Yongjin Xu, Pratik Choudhary, Richard M. Bergenstal.